US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist
  • 1.620
  • -0.120-6.90%
Close May 5 16:00 ET
  • 1.630
  • +0.010+0.62%
Post 19:59 ET
115.03MMarket Cap-1.07P/E (TTM)

About C4 Therapeutics Company

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in October 2015 and is headquartered in Watertown, MA.

Company Profile

SymbolCCCC
Company NameC4 Therapeutics
Listing DateOct 2, 2020
Issue Price19.00
Founded2015
CEOMr. Andrew J. Hirsch
MarketNASDAQ
Employees110
Fiscal Year Ends12-31
Address490 Arsenal Way,Suite 120
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-231-0700
Websitehttp://www.c4therapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Andrew J. Hirsch
  • Director, President and Chief Executive Officer
  • 5.24M
  • Mark Mossler
  • Chief Accounting Officer
  • --
  • Kendra R. Adams
  • Chief Financial Officer and Treasurer
  • 2.20M
  • Kelly A. Schick
  • Chief People Officer
  • --
  • Jolie M. Siegel
  • Chief Legal Officer and Secretary
  • --
  • Scott N. Boyle, M.B.A.,PhD
  • Chief Business Officer
  • --
  • Dr. Paige Mahaney, PhD
  • Chief Scientific Officer
  • --
  • Dr. Leonard M.J. Reyno, M.D.
  • Chief Medical Officer
  • 2.31M
  • Bruce L. Downey
  • Independent Director
  • 201.19K
  • Utpal Koppikar
  • Independent Director
  • 191.63K
  • Stephen L. Hoerter
  • Independent Director
  • 274.42K
  • Ronald Harold Wilfred Cooper
  • Independent Director
  • 346.20K
  • Owen P. Hughes, Jr
  • Independent Director
  • 179.13K
  • Dr. Stephen Fawell, PhD
  • Independent Director
  • 433.33K
  • Dr. Laura Bessen, M.D.
  • Independent Director
  • 180.63K
  • Dr. Kenneth C. Anderson, M.D.
  • Independent Director
  • 176.63K
  • Dr. Donna Roy Grogan, M.D.
  • Independent Director
  • 186.63K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 70.310
Sample Name
Sample Code
 8.110
Sample Name
Sample Code
 15.120
4
Collegium Pharmaceutical
COLL
27.780
5
Enerpac Tool
EPAC
42.050
Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More
Berkshire's 2025 Annual Shareholders Meeting

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 100.590
Sample Name
Sample Code
 126.570
Sample Name
Sample Code
 599.270
4
Microsoft
MSFT
436.170
5
Alphabet-C
GOOG
166.050
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 2.180
Sample Name
Sample Code
 3.640
Sample Name
Sample Code
 8.200
4
Argo Blockchain
ARBK
0.4151
5
Coinbase
COIN
199.400
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -